Author:
Wang Hui-Ching,Luo Chi-Wen,Chen Tzu-Yi,Chen Yi-Zi,Fang Shao-Yu,Lai Chiao-Ying,Hung Wen-Chun,Wu Chun-Chieh,Chen Li-Tzong,Liu Yi-Chang,Pan Mei-Ren
Funder
Kaohsiung Medical University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Ministry of Science and Technology, Taiwan
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference45 articles.
1. Cancer statistics, 2019;Siegel;CA: a cancer journal for clinicians,2019
2. Epidemiology of pancreatic cancer: global trends;Rawla;Etiology and Risk Factors, World journal of oncology,2019
3. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N. Engl. J. Med.,2013
4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N. Engl. J. Med.,2011
5. Pancreatic cancer chemoresistance to gemcitabine;Amrutkar;Cancers,2017
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献